Trending Now
Myovant Sciences (NYSE: MYOV) Announces a $41.1 million Total Revenue for...
Myovant Sciences (NYSE: MYOV) is a healthcare corporation that mainly focuses on redefining men and women’s healthcare which recently announced financial results and corporate updates...
DIH Holding US, Inc. (DHAI): Pioneering Rehabilitation with Cutting-Edge Technology
Let’s talk about something truly inspiring: the future of rehabilitation. On December 23, 2024, DIH Holding US, Inc. (NASDAQ: DHAI) announced...
Predictive Oncology Inc. (Nasdaq: POAI): A Transformative Acquisition by Renovaro Inc.
The biotechnological domain is currently abuzz with developments surrounding the acquisition of Predictive Oncology Inc. (Nasdaq: POAI) by Renovaro Inc. (Nasdaq: RENB)....
Popular News
Akcea Therapeutics Inc. (NASDAQ:AKCA) And Ionis Pharmaceuticals Inc. (NASDAQ:IONS) Announce Publication...
Akcea Therapeutics Inc. (NASDAQ:AKCA), the majority-owned Ionis Pharmaceuticals Inc. (NASDAQ:IONS) affiliate, and Ionis Pharmaceuticals have announced the publications of its long-term data from the...
MAKE IT MODERN
LATEST REVIEWS
Coherus BioSciences Inc. (NASDAQ:CHRS) Reports Product Revenue Of $113.6 Million In...
Coherus BioSciences Inc. (NASDAQ:CHRS) has announced its financial results for Q3 2020 and nine months ended September 30, 2020, and also provided corporate updates.
Coherus...
MAKE IT MODERN
PERFORMANCE TRAINING
Brickell Biotech Inc. (NASDAQ: BBI) Enters Licensing Agreement For Carna Biosciences Inc.’s Stimulator of...
Brickell Biotech Inc. (NASDAQ: BBI) and Carna Biosciences Inc. have announced the signing of a licensing agreement pursuant to which Brickell will receive exclusive...
ADC Therapeutics (NYSE:ADCT) Files Biologics License Application With the FDA For Loncastuximab Tesirine In...
ADC Therapeutics SA (NYSE:ADCT) has submitted a Biologics Licence Application (BLA) to the FDA for loncastuximab tesirine for treating patients with refractory or relapsed...
Medical Device Stocks in Sweet Spot as Correction Creates Historic Opportunity (MDT, EMED, ZYXI,...
One positive spin we can put on the “great growth stock bear market of 2022” – which, let’s face it, is what...
Ocugen Inc (NASDAQ: OCGN) Enters The Canadian Market With Covaxin: Explores Commercialization In Other...
Ocugen Inc (NASDAQ: OCGN) in alliance with Bharat Biotech develops Covid vaccine – Covaxin, which can act against new coronavarius variants.
Invesco QQQ Trust Series 1 (QQQ) Falters as Goldman Sachs Misses Revenue Estimates
Goldman Sachs reported earnings of $8.79 per share, surpassing the estimated $8.10 per share. However, the company's revenue of $12.22 billion fell...
MAKE IT MODERN
